Universal Therapeutics Group Sdn Bhd
Established in 2014 as Hesed Baracah Medical Group Limited and rebranded as Universal Therapeutics Group in 2020, we are a leading provider of In Vitro Diagnostics (IVDs) headquartered in Malaysia. Our state-of-the-art manufacturing facility has been certified with the ISO13485:2016 QMS, ensuring the highest standards of quality and performance for our IVDs. With our commitment to accuracy, reliability, and affordability, we have become a trusted partner for IVDs, serving customers across the globe. Our purpose at Universal Therapeutics is strive to make a positive impact in the healthcare industry and improve the lives of those we serve.
See below for the latest Universal Therapeutics Group Sdn Bhd News, Analysis, Profit Results, Share Price Information and Commentary
Commentary
Why bigger digesters alone won't solve Asia's renewable energy challenge
Only the agile will win across ASEAN’s evolving markets
Scaling for resilience: What Asia Pacific’s bioenergy markets can learn from each other
Asia is leading payments modernisation and banks can't afford to fall behind
To outsmart modern fraud, we must first know the enemy
Why Western firms keep misreading the Chinese and Korean trust architecture
Platinum cards, paper-thin compliance?
How Asian enterprises can deliver modern, data-driven HR on time and on budget
Why high turnover persists in hospitality, and what’s changing
Energy price volatility highlights structural gaps for managing FX risk in APAC